Serum hormones in men with human immunodeficiency virus-associated wasting

Adrian S Dobs, Walter L. Few, Marc R. Blackman, S. Mitchell Harman, Donald R. Hoover, Neil M H Graham

Research output: Contribution to journalArticle

Abstract

Weight loss is commonly associated with increased morbidity and mortality in individuals with human immunodeficiency virus (HIV) infection. We performed a nested case-control study of 26 HIV-infected subjects recruited from a cohort of gay men enrolled in the Multicenter Acquired Immunodeficiency Syndrome Cohort Study. To test the hypothesis that hormonal changes precede and may induce the wasting syndrome, we performed a nested case-control study and analyzed serum gonadal steroids and GH in samples of HIV-infected men with or without weight loss, uncomplicated by diarrhea or ever having an opportunistic infection. We studied 13 cases (mean age ± SD, 45 ± 7.2 yr) with a mean weight loss of 13 ± 3.6%, considered to have the wasting syndrome by Centers for Disease Control criteria(weight loss of > 10%) and 13 controls matched for age and duration of follow-up. Serum bioavailable testosterone (T) levels decreased in the case group (P <0.05) before the definition of wasting was attained, although weight loss had already begun. More impressive declines occurred in serum T (P = 0.012), free T (P = 0.0025), and bioavailable T (P <0.0001) during the 6 months immediately before documentation of wasting. These changes were concurrent with an increase in serum FSH (P = 0.0135) without a change in serum LH. We conclude that a decline in bioavailable T occurs early in the course of events leading to wasting, suggesting that changes in gonadal hormones may contribute to the multifactorial etiology of the wasting syndrome.

Original languageEnglish (US)
Pages (from-to)4108-4112
Number of pages5
JournalJournal of Clinical Endocrinology and Metabolism
Volume81
Issue number11
DOIs
StatePublished - 1996

Fingerprint

Viruses
Weight Loss
Wasting Syndrome
HIV
Hormones
Serum
Case-Control Studies
Disease control
Gonadal Hormones
Opportunistic Infections
Virus Diseases
Centers for Disease Control and Prevention (U.S.)
Documentation
Testosterone
Diarrhea
Acquired Immunodeficiency Syndrome
Cohort Studies
Steroids
Morbidity
Mortality

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Serum hormones in men with human immunodeficiency virus-associated wasting. / Dobs, Adrian S; Few, Walter L.; Blackman, Marc R.; Harman, S. Mitchell; Hoover, Donald R.; Graham, Neil M H.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 81, No. 11, 1996, p. 4108-4112.

Research output: Contribution to journalArticle

Dobs, Adrian S ; Few, Walter L. ; Blackman, Marc R. ; Harman, S. Mitchell ; Hoover, Donald R. ; Graham, Neil M H. / Serum hormones in men with human immunodeficiency virus-associated wasting. In: Journal of Clinical Endocrinology and Metabolism. 1996 ; Vol. 81, No. 11. pp. 4108-4112.
@article{ec2bfc06dd914df3b4c2801a2d9c2c7b,
title = "Serum hormones in men with human immunodeficiency virus-associated wasting",
abstract = "Weight loss is commonly associated with increased morbidity and mortality in individuals with human immunodeficiency virus (HIV) infection. We performed a nested case-control study of 26 HIV-infected subjects recruited from a cohort of gay men enrolled in the Multicenter Acquired Immunodeficiency Syndrome Cohort Study. To test the hypothesis that hormonal changes precede and may induce the wasting syndrome, we performed a nested case-control study and analyzed serum gonadal steroids and GH in samples of HIV-infected men with or without weight loss, uncomplicated by diarrhea or ever having an opportunistic infection. We studied 13 cases (mean age ± SD, 45 ± 7.2 yr) with a mean weight loss of 13 ± 3.6{\%}, considered to have the wasting syndrome by Centers for Disease Control criteria(weight loss of > 10{\%}) and 13 controls matched for age and duration of follow-up. Serum bioavailable testosterone (T) levels decreased in the case group (P <0.05) before the definition of wasting was attained, although weight loss had already begun. More impressive declines occurred in serum T (P = 0.012), free T (P = 0.0025), and bioavailable T (P <0.0001) during the 6 months immediately before documentation of wasting. These changes were concurrent with an increase in serum FSH (P = 0.0135) without a change in serum LH. We conclude that a decline in bioavailable T occurs early in the course of events leading to wasting, suggesting that changes in gonadal hormones may contribute to the multifactorial etiology of the wasting syndrome.",
author = "Dobs, {Adrian S} and Few, {Walter L.} and Blackman, {Marc R.} and Harman, {S. Mitchell} and Hoover, {Donald R.} and Graham, {Neil M H}",
year = "1996",
doi = "10.1210/jc.81.11.4108",
language = "English (US)",
volume = "81",
pages = "4108--4112",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "11",

}

TY - JOUR

T1 - Serum hormones in men with human immunodeficiency virus-associated wasting

AU - Dobs, Adrian S

AU - Few, Walter L.

AU - Blackman, Marc R.

AU - Harman, S. Mitchell

AU - Hoover, Donald R.

AU - Graham, Neil M H

PY - 1996

Y1 - 1996

N2 - Weight loss is commonly associated with increased morbidity and mortality in individuals with human immunodeficiency virus (HIV) infection. We performed a nested case-control study of 26 HIV-infected subjects recruited from a cohort of gay men enrolled in the Multicenter Acquired Immunodeficiency Syndrome Cohort Study. To test the hypothesis that hormonal changes precede and may induce the wasting syndrome, we performed a nested case-control study and analyzed serum gonadal steroids and GH in samples of HIV-infected men with or without weight loss, uncomplicated by diarrhea or ever having an opportunistic infection. We studied 13 cases (mean age ± SD, 45 ± 7.2 yr) with a mean weight loss of 13 ± 3.6%, considered to have the wasting syndrome by Centers for Disease Control criteria(weight loss of > 10%) and 13 controls matched for age and duration of follow-up. Serum bioavailable testosterone (T) levels decreased in the case group (P <0.05) before the definition of wasting was attained, although weight loss had already begun. More impressive declines occurred in serum T (P = 0.012), free T (P = 0.0025), and bioavailable T (P <0.0001) during the 6 months immediately before documentation of wasting. These changes were concurrent with an increase in serum FSH (P = 0.0135) without a change in serum LH. We conclude that a decline in bioavailable T occurs early in the course of events leading to wasting, suggesting that changes in gonadal hormones may contribute to the multifactorial etiology of the wasting syndrome.

AB - Weight loss is commonly associated with increased morbidity and mortality in individuals with human immunodeficiency virus (HIV) infection. We performed a nested case-control study of 26 HIV-infected subjects recruited from a cohort of gay men enrolled in the Multicenter Acquired Immunodeficiency Syndrome Cohort Study. To test the hypothesis that hormonal changes precede and may induce the wasting syndrome, we performed a nested case-control study and analyzed serum gonadal steroids and GH in samples of HIV-infected men with or without weight loss, uncomplicated by diarrhea or ever having an opportunistic infection. We studied 13 cases (mean age ± SD, 45 ± 7.2 yr) with a mean weight loss of 13 ± 3.6%, considered to have the wasting syndrome by Centers for Disease Control criteria(weight loss of > 10%) and 13 controls matched for age and duration of follow-up. Serum bioavailable testosterone (T) levels decreased in the case group (P <0.05) before the definition of wasting was attained, although weight loss had already begun. More impressive declines occurred in serum T (P = 0.012), free T (P = 0.0025), and bioavailable T (P <0.0001) during the 6 months immediately before documentation of wasting. These changes were concurrent with an increase in serum FSH (P = 0.0135) without a change in serum LH. We conclude that a decline in bioavailable T occurs early in the course of events leading to wasting, suggesting that changes in gonadal hormones may contribute to the multifactorial etiology of the wasting syndrome.

UR - http://www.scopus.com/inward/record.url?scp=0029824328&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029824328&partnerID=8YFLogxK

U2 - 10.1210/jc.81.11.4108

DO - 10.1210/jc.81.11.4108

M3 - Article

C2 - 8923868

AN - SCOPUS:0029824328

VL - 81

SP - 4108

EP - 4112

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 11

ER -